10 ten best, average and worst Points of Pharmaceutical marketing.
Basically this presentation is related to the pharmaceutical marketing. . . that which type of strategies become best , worst and average for the pharmaceutical marketing.
20. Easy access to information is a major pro
for health care professionals. It has been
observed that many health care
professionals are searching the web for
informational purposes. More timely
information is made available over the
web, as compared to the lag time
experienced in current print media.
21.
22. Over the past 5-7 years, the Internet has
become an extremely viable source of
information for consumers. Another major
advantage is the vast amount of information
available for consumers. There are constantly
new and innovative sites being developed for
consumers by various companies, including
some pharmaceutical manufacturers.
Consumers seeking information related to
pharmaceutical products can get much more
detailed information via the Internet than is
offered at the physician's office.
24. Sure, a big part of launching a drug
revolves around the drug itself -
developing the chemical composition,
submitting the drug for approval, ensuring
formulary positioning, and more all focus
on the physical product. But often lost in
the mix is the customer and market.
25. A good product is important. But just as, if
not more, important is the team guiding
that product to market, and pushing it
towards success.
26. For effective pre-launch planning, company
departments must work together. Why is
cross-functional work necessary for
successful pre-launches? Consider product
research and development, which can often
take place in a vacuum. With a cross-
functional team, R&D can learn the concerns
and needs of marketers, incorporating new
research points that can be instrumental in
later positioning and sales.
27. Everyone wants the competitive
advantages of being first to the market, or
first to address a unique need.
28. Launching a new product can be a very
educational experience for all those
involved. But without the means of
measuring success, tracking activities, and
learning from mistakes, all the lessons of
launch can be forgotten, creating a missed
opportunity to improve future launches.
29. Consistency is a critical business practice.
But many companies can take this desire
overboard, fitting every new product into
the same mold, and eliminating the
creativity and uniqueness of each product.
30. No matter how much you plan ahead, new
drug development is inherently risky in
today's environment. Increasingly, pharma
managers and marketers need a way to
assess the potential of new products, and
the likelihood of success upon launch.
Analytics models can provide insight on
what drives your target consumers, and
help predict actual launch results.
31. Information sometimes provided on the
Internet is too technical or difficult for the lay
consumer to understand. This may result in
more confusion to consumers regarding the
product for which they are seeking
information. It has been observed that along
with other relevant product information, an
extensive 'side effect' profile of
pharmaceutical products is sometimes
provided at the product-related Web sites.
32. The information sometimes provided is too
simple for the health care professional, as
some Web sites are geared to the lay
public. Another disadvantage is that some
clinical studies described on the Internet
do not always contain references to
medical literature. No references may
affect the credibility of these sites.
33. The Web sites are usually not created by
healthcare professionals, and thus the
authority is absent in determining certain
errors. These Web sites should be
questionable to consumers. Most
companies hire non-medical personnel
who have the technical skills needed to
create a Web site, but mistakes may occur
in transcribing information, thereby going
unnoticed.